ATE317907T1 - Nicht-menschliches transgenes tier, welches ca- ahr exprimiert - Google Patents

Nicht-menschliches transgenes tier, welches ca- ahr exprimiert

Info

Publication number
ATE317907T1
ATE317907T1 AT01977048T AT01977048T ATE317907T1 AT E317907 T1 ATE317907 T1 AT E317907T1 AT 01977048 T AT01977048 T AT 01977048T AT 01977048 T AT01977048 T AT 01977048T AT E317907 T1 ATE317907 T1 AT E317907T1
Authority
AT
Austria
Prior art keywords
cancer
ahr
investigation
study
human animals
Prior art date
Application number
AT01977048T
Other languages
English (en)
Inventor
Lorenz Poellinger
Jaqueline Mcguire
Wiklund Annika Hanberg
Patrik Andersson
Original Assignee
Index Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Index Pharmaceuticals Ab filed Critical Index Pharmaceuticals Ab
Application granted granted Critical
Publication of ATE317907T1 publication Critical patent/ATE317907T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0331Animal model for proliferative diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01977048T 2000-10-26 2001-10-25 Nicht-menschliches transgenes tier, welches ca- ahr exprimiert ATE317907T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24354800P 2000-10-26 2000-10-26

Publications (1)

Publication Number Publication Date
ATE317907T1 true ATE317907T1 (de) 2006-03-15

Family

ID=22919182

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01977048T ATE317907T1 (de) 2000-10-26 2001-10-25 Nicht-menschliches transgenes tier, welches ca- ahr exprimiert

Country Status (6)

Country Link
US (1) US7098376B2 (de)
EP (1) EP1328652B1 (de)
AT (1) ATE317907T1 (de)
AU (1) AU2001296198A1 (de)
DE (1) DE60117280T2 (de)
WO (1) WO2002034928A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569352B2 (en) 2003-05-14 2009-08-04 Index Pharmaceuticals Ab Method for identifying modulators of the dioxin/aryl hydrocarbon receptor (AHR)
AU2011282776B2 (en) 2010-07-27 2014-06-12 Boston Medical Center Corporation Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
EP3224381B1 (de) 2014-11-25 2019-09-04 The Brigham and Women's Hospital, Inc. Verfahren zur identifizierung von personen mit einer prädisposition für eine kardiometabolische krankheit oder davon betroffenen personen
WO2016085876A1 (en) 2014-11-25 2016-06-02 The Broad Institute Inc. Clonal haematopoiesis
CN110810323B (zh) * 2019-04-23 2021-09-14 中国科学院脑科学与智能技术卓越创新中心 制备具有强迫仪式样行为的非人灵长类动物模型的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378822A (en) * 1993-04-08 1995-01-03 Wisconsin Alumni Research Nucleic acids encoding murine and human Ah receptors
US5650283A (en) * 1993-04-08 1997-07-22 Northwestern University Biological assay for detecting agonists to the Ah receptor
US7105647B1 (en) 1997-11-28 2006-09-12 Wisconsin Alumni Research Foundation cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use

Also Published As

Publication number Publication date
US20040088743A1 (en) 2004-05-06
US7098376B2 (en) 2006-08-29
DE60117280D1 (de) 2006-04-20
AU2001296198A1 (en) 2002-05-06
DE60117280T2 (de) 2006-11-02
EP1328652B1 (de) 2006-02-15
WO2002034928A1 (en) 2002-05-02
EP1328652A1 (de) 2003-07-23

Similar Documents

Publication Publication Date Title
EP1534066A4 (de) Alpha(1,3)-galactosyltransferase-nullzellen, selektionsverfahren und davon produziertes alpha(1,3)-galactosyltransferase-nullschwein
EP2604111A3 (de) Tiermodelle und therapeutische Moleküle
NO20080362L (no) CD19-antistoffer og deres anvendelser
MX2010005966A (es) Conjugados de anticuerpo monoclonal-molecula asociada dirigidos a la proteina tirosina-cinasa 7 (ptk7).
DK1492766T3 (da) Forbedret CC-1065-analogsyntese
CY1111518T1 (el) Tgf βητα 1 ειδικα αντισωματα
MXPA03004793A (es) Roedores transgenicos transcromosomales para elaborar anticuerpos humnanos.
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
EP1608255A4 (de) Endothelzellen-expressionsmuster in der brust
WO2003089580A3 (en) Cancer models
WO2007035213A3 (en) Transgenic ungulates expressing ctla4-ig and uses thereof
ATE317907T1 (de) Nicht-menschliches transgenes tier, welches ca- ahr exprimiert
WO2003096799A3 (en) Multiple closed nucleus breeding for swine production
ATE497976T1 (de) Spezifisch an vygfvracl-hla-a24 bindende t-zellen-rezeptoren
EA200800769A1 (ru) Перенос клеточных ядер
BRPI0509916A (pt) guitarra clássica ergonÈmica
WO2005099449A3 (en) Animal model, cells, and treatment for malignant melanoma
WO2005037191A3 (en) Expression of dominant negative transmembrane receptors in the milk of transgenic animals
AU2003216489A1 (en) Methods and compositions for pharmacological and toxicological evaluation of test agents
CY1110482T1 (el) Μεταλλαγμενο θηλαστικο εκτος του ανθρωπου για την εκφραση της υπομοναδας α6 του νικοτινικου υποδοχεα της ακετυλοχολινης και χρηση για τη διαλογη ουσιων ικανων να αλληλεπιδρουν με τον υποδοχεα αυτον
AU6248201A (en) Model for neurodegenerative disease
WO2002019811A3 (en) Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
ES1053907U (es) Bateria eliptica para cria de bivalvos en mar abierto.
RU2003124795A (ru) Способ создания экспериментальных опухолей брюшной полости
ATE443438T1 (de) Liegeboxkonstruktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties